NCT06281678 A Study of IBI363 in Subjects with Advanced Solid Malignancies Status RECRUITING Phase PHASE2
NCT06277674 Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI Status RECRUITING Phase PHASE2
NCT06277388 Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06276283 DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29) Status RECRUITING Phase PHASE2
NCT06268210 Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06254599 A Study Of SY-3505 Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC Status NOT_YET_RECRUITING Phase PHASE3
NCT06253520 Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06249854 Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT06247826 Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion Status RECRUITING Phase NA
NCT06239194 Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06238882 Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. Status RECRUITING Phase NA
NCT06238479 A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06236438 Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Status RECRUITING Phase PHASE2/PHASE3
NCT06235242 GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer Status TERMINATED Phase NA
NCT06232265 An Observational Study on Predicting the Efficacy of Immunotherapy for NSCLC Based on LIRAscore Status RECRUITING Phase N/A
NCT06225804 A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE1
NCT06224504 Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione Status COMPLETED Phase NA